Experience in the therapy of iron deficiency anemia in pregnant women

Irina N. Medvedeva; A. B Khuraseva

doi:10.18821/2313-8726-2016-3-1-23-25

V.F.Snegirev Archives of Obstetrics and Gynecology ›› 2016, Vol. 3 ›› Issue (1) : 23 -25. DOI: 10.18821/2313-8726-2016-3-1-23-25

Original study articles

research-article

Experience in the therapy of iron deficiency anemia in pregnant women

Author information +

History +

PDF

Abstract

There was executed the examination and treatment of 68 pregnant patients with diagnosed mild iron deficiency anemia (IDA) at gestational age from 12th to 34th weeks. There was estimated the efficacy of the combine preparation of iron and trace elements (iron gluconate, copper gluconate, manganese gluconate) in the treatment of IDA. Early detection of IDA, timely prevention and treatment with the use of this preparation allowed to reduce the rate of obstetric and perinatal complications.

Keywords

pregnancy / anemia / treatment of iron deficiency anemia / extragenital pathology / morbidity rate / prophylaxis

Cite this article

Download citation ▾

Irina N. Medvedeva, A. B Khuraseva. Experience in the therapy of iron deficiency anemia in pregnant women. V.F.Snegirev Archives of Obstetrics and Gynecology, 2016, 3(1): 23-25 DOI:10.18821/2313-8726-2016-3-1-23-25

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Серов В.Н., Жаров Е.В., Охапкин М.Б., Архипова В.И. Современные принципы профилактики и лечения железодефицитной анемии у беременных. Журнал Российского общества акушеров-гинекологов. 2004; (4): 21-3.

[2]	Стуклов Н.И., Семенова Е.Н. Железодефицитная анемия. Современная тактика диагностики и лечения, критерии эффективности терапии. Клин. мед. 2013; (12): 61-7.

[3]	Breymann С. Iron defi ciency and anaemia in pregnancy: modem aspect of diagnosis and therapy. Blood Cells Mol. Dis. 2002; 29 (3): 506-16.

[4]	Rayman M.P., Barlis J., Evans R.W., Redman C.W., King L.J. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am. J. Obstetr. Gynecol. 2002; 187 (2): 412-8.

[5]	Михайлов И.Б. Железодефицитные состояния: выбор препаратов железа. Методическое пособие для врачей. СПб.; 2014.

[6]	Громова О.А., Торшин И.Ю., Хаджидис А.К. Нежелательные эффекты сульфата железа в акушерской, педиатрической и терапевтической практике. Земский врач. 2010; (2): 1-8.

[7]	Souza A.I., Batista Filho M., Bresani C.C., Ferreira L.O., Figueiroa J.N. Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad. Saude Publ. 2009; 25 (6): 1225-33.

[8]	Troost F.J., Saris W.H., Haenen G.R., Bast A., Brummer R.J. New method to study oxidative damage and antioxidants in the human small bowel: effects of iron application. Am. J. Physiol. Gastrointest. Liver Physiol. 2003; 285 (2): G354-9.

[9]	Коноводова Е.Н. Железодефицитные состояния: когда и кому назначать Тотему? Фарматека. 2005; (6): 34-40.

[10]	Gambling L., Danzeisen R., Fosset C., Andersen H.S., Dunford S., Srai S.K. et al. Iron and copper interactions in development and the effect on pregnancy outcome. J. Nutr. 2003; 133 (5, Suppl. 1): 1554S-6S.